Announcement • May 12
Solésence, Inc Announces Commercial Availability Of WHSPR™ and Chromalüm™
Solésence, Inc. had announced the commercial availability of two proprietary platform technologies: WHSPR™ and Chromalüm™. Both technology platforms are available through finished goods for brand partners globally, and represent a significant expansion of the Company's ingredient technology portfolio. The launch of WHSPR™ and Chromalüm™ advances Solésence's mission to deliver joy through innovation, inclusivity, and the science of beautiful skin. Each platform was developed to address longstanding formulation constraints within health-infused beauty. Consistent with the Company's vertically integrated model, each technology platform is embedded within Solésence's finished goods offering, allowing brand partners to access differentiated product claims, expanded category reach, and clinically validated performance. WHSPR™, which has received multiple patents in the United States and globally, is a delivery system for allantoin, which is a well-known skin health ingredient on the OTC skin protectant monograph. WHSPR™ enables the use of allantoin at high concentrations with stability, including in anhydrous product formats such as serums, balms, and face and lip oils, where stability and solubility constraints have historically prevented its effective application. By embedding WHSPR™ within its finished goods, Solésence allows brand partners to access OTC skin health claims and sensitive skin-focused products across skincare, suncare, and color cosmetics categories. Independent clinical studies demonstrated that WHSPR™ delivers statistically significant improvements across all primary endpoints, with 100% of study panelists showing measurable improvement in skin barrier recovery, barrier strength, hydration, and redness reduction. Specific outcomes include up to 63% reduction in redness at 48 hours compared to no reduction in untreated control, up to 36% improvement in skin barrier recovery at 48 hours compared to 4% in untreated control, 23% improvement in skin barrier strength compared to no improvement in untreated control, and immediate hydration improvements of up to 112% above baseline, with up to 18% sustained over two weeks. WHSPR™ supports skin protectant and lip protectant claims under the applicable FDA OTC monograph, enabling brand partners to substantiate regulatory-compliant marketing positions in product categories that have previously been inaccessible for allantoin-based claims. Because Solésence delivers these benefits through finished goods, partners receive products that are fully formulated, clinically supported, and commercially ready, with the aesthetic sensorial profile expected of a premium daily-use cosmetic. Chromalüm™ is a high-brilliance precision color technology designed to work in conjunction with the Company’s globally patented, award-winning Kleair™ technology. When combined with Solésence Kleair™, the system enables the integration of broad-spectrum sun protection — including targeted high-energy visible, or HEV, light protection in the 400 to 450 nanometer range — into color cosmetics without compromising color quality or aesthetic performance. Leveraging globally accepted GRAS-status colorants alongside Kleair™, Chromalüm™ provides brand partners with a fully integrated color and protection system for product categories where achieving efficacious SPF and HEV protection in high-sheer formulas has historically been difficult. The technology supports both high-sheer and full-coverage formulations across a broad range of product formats, and is compatible with Solésence Kleair™ to enable fully integrated system formulation. Chromalüm™ also supports high-SPF and water-resistant formula development, extending its applicability to active and sport-oriented color cosmetic products. Preclinical data demonstrates best-in-class HEV protection performance relative to comparable available technologies. As with all Solésence technologies, Chromalüm™ is made available to brand partners through finished goods, with Solésence handling formulation, manufacturing, and quality assurance end to end. Since the first Solésence brand partner product launch in 2018, the Company has supported dozens of beauty brands across skincare, suncare, and color cosmetics categories on a global basis. The commercial launch of WHSPR™ and Chromalüm™ further extends Solésence's suite of transformative technologies and reinforces the Company's vertically integrated model — enabling brand partners to access breakthrough innovation, fully realized in finished goods, through a single manufacturing relationship. For more information about WHSPR™ and Chromalüm™, or to explore a brand partnership, please contact Solésence at solesence.com.
